| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.2 | 0.001 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.17 | 0.005 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |